Rivastigmine Tartrate
NDC 72241-013, Rivastigmine Tartrate, capsule, from Modavar Pharmaceuticals LLC.
- Product NDC
- 72241-013
- Status
- Listed
- Labeler
- Modavar Pharmaceuticals LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203844
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72241-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE TARTRATE4.5 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72241-013-03 | 72241001303 | 60 CAPSULE in 1 BOTTLE (72241-013-03) |
| 72241-013-10 | 72241001310 | 500 CAPSULE in 1 BOTTLE (72241-013-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/209f3b02-0acf-46e9-b355-91c918a20eb3NADAC price for package 72241001303
GET /v1/drugs/nadac/72241001303
Use it
Look up 72241-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72241-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72241-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.